CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
7.54
-0.60 (-7.37%)
At close: Aug 14, 2026, 4:00 PM EDT
7.59
+0.05 (0.68%)
After-hours: Aug 14, 2026, 5:55 PM EDT

CorMedix Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
187.17163.06-17.93-46.34-29.7-28.21
Depreciation & Amortization
35.3114.550.310.070.080.06
Other Amortization
0.40.4----
Loss (Gain) From Sale of Assets
-0.09-0.09----
Loss (Gain) From Sale of Investments
-4.36-5.36----
Stock-Based Compensation
16.3213.836.135.494.075.04
Provision & Write-off of Bad Debts
0.250.250.14---
Other Operating Activities
10.25-18.860.150.130.120.12
Change in Accounts Receivable
-89.65-90.92-51.79-0.04-0.04
Change in Inventory
-10.31-3.48-5.49-2.1100.15
Change in Accounts Payable
1.43.33-2.562.08-0.011.08
Change in Other Net Operating Assets
107.2498.3420.442.261.030.65
Operating Cash Flow
253.94175.05-50.62-38.41-24.36-21.16
Operating Cash Flow Growth
733.59%-----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-3.52-2.26-0.12-0.33-0.22-1.43
Cash Acquisitions
-308.51-308.51----
Investment in Securities
26.412.3421.35-16.73-3.49-7.71
Investing Cash Flow
-285.62-308.4321.23-17.06-3.71-9.13

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-150----
Long-Term Debt Repaid
--0.19----
Net Debt Issued (Repaid)
149.5149.81----
Issuance of Common Stock
7.3696.5526.6156.1217.941.76
Repurchase of Common Stock
-19.86-1.99-0.29-0.2--
Other Financing Activities
-7.05-5.92----
Financing Cash Flow
129.95238.4526.3255.9217.941.76

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0--00-0.01-0.01
Net Cash Flow
98.27105.07-3.070.45-10.1811.45

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
250.42172.79-50.73-38.74-24.58-22.58
Free Cash Flow Growth
723.50%-----
Free Cash Flow Margin
54.17%55.43%-116.70%--37573.53%-11826.24%
Free Cash Flow Per Share
2.742.15-0.86-0.76-0.61-0.60
Levered Free Cash Flow
178.14108.51-44.72-22.97-14.03-12.73
Unlevered Free Cash Flow
179.48109.85-44.69-22.95-14.01-12.72

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
2.820.020.040.030.030.02
Change in Working Capital
8.687.27-39.412.231.071.84
SEC Filings: 10-K · 10-Q